Somatotrope pituitary function in professional soccer players

Somatotrope pituitary function in professional soccer players - SPFPSP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00011153

Enrollment

Registered

2016-10-18

Start date

2015-04-10

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E23.0

Interventions

Group 1: Glucagon stimulation test at 08:00 a.m. after an overnight fast -subcutaneous injection of, weight depending, 1mg/1,5mg Glucagon (GlucaGen) (1mg80 kg) -blood sampling for GH at baseline foll

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: At least 10 years of professional soccer training (= three times a week)

Exclusion criteria

Exclusion criteria: Diabetes mellitus Heart failure Untreated Hypertension Epilepsy Age under 18 years or over 50 years

Design outcomes

Primary

Measure	Time frame
Primary outcome measure was the evaluation of the somatotrope axis in professional soccer players meeting the inclusion criteria and referred to glucagon stimulation test. Soccer players were screened from april 2015 to may 2016. Data concerning age, duration of soccer playing, systemic risk factors and history of brain injury in the past were collected from each patient.	—

Secondary

Measure	Time frame
Incidence of other hormone deficiencies	—

Countries

Germany

Contacts

Public ContactPia Roser

Universitätsklinikum Hamburg-Eppendorf

p.roser@uke.de00491781948420

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026